Literature DB >> 16598657

Influence of pertussis toxin on CD1a isoform expression in human dendritic cells.

Angelo Martino1, Elisabetta Volpe, Giovanni Auricchio, Vittorio Colizzi, Patrizia Morena Baldini.   

Abstract

Pertussis toxin (PTX) is an exotoxin produced by Bordetella pertussis. It is known to exert adjuvant activities inducing Th1-launched immune responses. In this study, we show that PTX can selectively block the expression of CD1a isoform during the differentiation of human monocytes into dendritic cells. In fact, dendritic cells differentiated from monocytes in the presence of PTX do not express CD1a on their surface, unlike CD1b and CD1c isoforms, which are normally regulated. The impaired CD1a expression on cell membrane depends, at least partially, on decreased mRNA transcription and does not affect cellular capability to respond to other maturation stimuli. Since CD1a(+) dendritic cells are involved in the early steps of primary immune response, the interference of PTX in the CD1a expression may be relevant for its employment as adjuvant.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16598657     DOI: 10.1007/s10875-006-9009-3

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  30 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Cell-surface bound pertussis toxin induces polyclonal T cell responses with high levels of interferon-gamma in the absence of interleukin-12.

Authors:  Ayako Wakatsuki; Persephone Borrow; Kevin Rigley; Peter C L Beverley
Journal:  Eur J Immunol       Date:  2003-07       Impact factor: 5.532

3.  Role of carbohydrate recognition domains of pertussis toxin in adherence of Bordetella pertussis to human macrophages.

Authors:  J van't Wout; W N Burnette; V L Mar; E Rozdzinski; S D Wright; E I Tuomanen
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

4.  CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells.

Authors:  L J Zhou; T F Tedder
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

Review 5.  CD1a and antitumour immune response.

Authors:  Giampiero La Rocca; Rita Anzalone; Fabio Bucchieri; Felicia Farina; Francesco Cappello; Giovanni Zummo
Journal:  Immunol Lett       Date:  2004-08-15       Impact factor: 3.685

6.  Dendritic cells derived from BCG-infected precursors induce Th2-like immune response.

Authors:  Angelo Martino; Alessandra Sacchi; Nunzia Sanarico; Francesca Spadaro; Carlo Ramoni; Antonio Ciaramella; Leopoldo Paolo Pucillo; Vittorio Colizzi; Silvia Vendetti
Journal:  J Leukoc Biol       Date:  2004-07-07       Impact factor: 4.962

7.  Bordetella pertussis infection of primary human monocytes alters HLA-DR expression.

Authors:  Jennifer A Shumilla; Vashti Lacaille; Tara M C Hornell; Jennifer Huang; Supraja Narasimhan; David A Relman; Elizabeth D Mellins
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

8.  Sequential production of Th1 and Th2 cytokines in response to live bacillus Calmette-Guérin.

Authors:  B Sander; U Skansén-Saphir; O Damm; L Håkansson; J Andersson; U Andersson
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

9.  Enhancement of the intensity, persistence, and passive transfer of delayed-type hypersensitivity lesions by pertussigen in mice.

Authors:  W A Sewell; J J Munoz; M A Vadas
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

10.  Primary role for Gi protein signaling in the regulation of interleukin 12 production and the induction of T helper cell type 1 responses.

Authors:  J He; S Gurunathan; A Iwasaki; B Ash-Shaheed; B L Kelsall
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

View more
  11 in total

1.  Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis.

Authors:  Xuqing Zhang; Sara E Hester; Mary J Kennett; Alexia T Karanikas; Liron Bendor; David E Place; Eric T Harvill
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

2.  Pertussis toxin exacerbates and prolongs airway inflammatory responses during Bordetella pertussis infection.

Authors:  Carey E Connelly; Yezhou Sun; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

Review 3.  Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools.

Authors:  Nicholas H Carbonetti
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

Review 4.  Sphingosine 1-phosphate as a novel immune regulator of dendritic cells.

Authors:  Angelo Martino
Journal:  J Biosci       Date:  2007-09       Impact factor: 1.826

5.  Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice.

Authors:  Charlotte Andreasen; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

6.  Effect of sialic acid loss on dendritic cell maturation.

Authors:  Hélio J Crespo; M Guadalupe Cabral; Alexandra V Teixeira; Joseph T Y Lau; Hélder Trindade; Paula A Videira
Journal:  Immunology       Date:  2009-01-12       Impact factor: 7.397

Review 7.  Exogenous control of the expression of Group I CD1 molecules competent for presentation of microbial nonpeptide antigens to human T lymphocytes.

Authors:  Angelo Aquino; Grazia Graziani; Ornella Franzese; Salvatore P Prete; Enzo Bonmassar; Laura Bonmassar; Stefania D'Atri
Journal:  Clin Dev Immunol       Date:  2011-03-22

8.  Bordetella pertussis infection exacerbates influenza virus infection through pertussis toxin-mediated suppression of innate immunity.

Authors:  Victor I Ayala; John R Teijaro; Donna L Farber; Susan G Dorsey; Nicholas H Carbonetti
Journal:  PLoS One       Date:  2011-04-20       Impact factor: 3.240

Review 9.  Rediscovering Pertussis.

Authors:  Manuela Zlamy
Journal:  Front Pediatr       Date:  2016-06-08       Impact factor: 3.418

Review 10.  Acellular Pertussis Vaccine Components: Today and Tomorrow.

Authors:  Kalyan K Dewan; Bodo Linz; Susan E DeRocco; Eric T Harvill
Journal:  Vaccines (Basel)       Date:  2020-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.